Molecular Alterations and New Drugs in Bile Duct Cancer

Earn CME for related activities: https://www.naccme.com/oln

In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Michel P. Ducreux discusses molecular alterations and new therapeutic advances in the treatment of bile duct cancer.

© 2019 Imedex, an HMP Company

• Loại